These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1361534)

  • 1. Pharmacokinetic study of gadolinium-DOTA in control and streptozocin diabetic rats.
    Michel A; Bonnet PA; Fernandez JP; Chambon C; Doucet D
    J Pharm Pharmacol; 1992 Nov; 44(11):902-6. PubMed ID: 1361534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gd-DOTA: characterization of a new paramagnetic complex.
    Bousquet JC; Saini S; Stark DD; Hahn PF; Nigam M; Wittenberg J; Ferrucci JT
    Radiology; 1988 Mar; 166(3):693-8. PubMed ID: 3340763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new biodegradable and biocompatible gadolinium (III) -polymer for liver magnetic resonance imaging contrast agent.
    Xiao Y; Xue R; You T; Li X; Pei F
    Magn Reson Imaging; 2015 Jul; 33(6):822-8. PubMed ID: 25839395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental study of DOTA-gadolinium. Pharmacokinetics and pharmacologic properties.
    Allard M; Doucet D; Kien P; Bonnemain B; Caillé JM
    Invest Radiol; 1988 Sep; 23 Suppl 1():S271-4. PubMed ID: 3198361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging of the pancreas in streptozotocin-induced diabetic rats: Gadofluorine P and Gd-DOTA.
    Cho HR; Lee Y; Doble P; Bishop D; Hare D; Kim YJ; Kim KG; Jung HS; Park KS; Choi SH; Moon WK
    World J Gastroenterol; 2015 May; 21(19):5831-42. PubMed ID: 26019447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gd-DOTA. Pharmacokinetics and tolerability after intravenous injection into healthy volunteers.
    Le Mignon MM; Chambon C; Warrington S; Davies R; Bonnemain B
    Invest Radiol; 1990 Aug; 25(8):933-7. PubMed ID: 2394577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer.
    Corot C; Schaefer M; Beauté S; Bourrinet P; Zehaf S; Bénizé V; Sabatou M; Meyer D
    Acta Radiol Suppl; 1997; 412():91-9. PubMed ID: 9240087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First in vivo MRI assessment of a self-assembled metallostar compound endowed with a remarkable high field relaxivity.
    Livramento JB; Weidensteiner C; Prata MI; Allegrini PR; Geraldes CF; Helm L; Kneuer R; Merbach AE; Santos AC; Schmidt P; Tóth E
    Contrast Media Mol Imaging; 2006; 1(1):30-9. PubMed ID: 17193598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion.
    Lancelot E
    Invest Radiol; 2016 Nov; 51(11):691-700. PubMed ID: 27175546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic study of tempo carboxylic acid, a nitroxyl MRI contrast media, in control and streptozocin diabetic rats.
    Michel A; Fernandez JP; Subra G; Pull L; Bonnet PA
    J Pharm Pharmacol; 1989 Aug; 41(8):561-3. PubMed ID: 2571702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyion complex micelle MRI contrast agents from poly(ethylene glycol)-b-poly(l-lysine) block copolymers having Gd-DOTA; preparations and their control of T(1)-relaxivities and blood circulation characteristics.
    Shiraishi K; Kawano K; Maitani Y; Yokoyama M
    J Control Release; 2010 Dec; 148(2):160-7. PubMed ID: 20804796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugate of arabinogalactan as a potential liver-targeting magnetic resonance imaging contrast agent.
    Xiao Y; Xue R; You T; Li X; Pei F; Wang X; Lei H
    Carbohydr Res; 2014 Aug; 395():9-14. PubMed ID: 24995911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
    Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and clearance of retained gadolinium in the brain: differences between linear and macrocyclic gadolinium based contrast agents in a mouse model.
    Kartamihardja AA; Nakajima T; Kameo S; Koyama H; Tsushima Y
    Br J Radiol; 2016 Oct; 89(1066):20160509. PubMed ID: 27459250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of a high-generation dendrimer-Gd-DOTA.
    Bryant LH; Jordan EK; Bulte JW; Herynek V; Frank JA
    Acad Radiol; 2002 May; 9 Suppl 1():S29-33. PubMed ID: 12019888
    [No Abstract]   [Full Text] [Related]  

  • 16. MR imaging of rat brain glioma: Gd-DTPA versus Gd-DOTA.
    Runge VM; Jacobson S; Wood ML; Kaufman D; Adelman LS
    Radiology; 1988 Mar; 166(3):835-8. PubMed ID: 3401296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oval window transport of Gd-dOTA from rat middle ear to vestibulum and scala vestibuli visualized by in vivo magnetic resonance imaging.
    Zou J; Poe D; Ramadan UA; Pyykkö I
    Ann Otol Rhinol Laryngol; 2012 Feb; 121(2):119-28. PubMed ID: 22397222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Size-dependent passage of liposome nanocarriers with preserved posttransport integrity across the middle-inner ear barriers in rats.
    Zou J; Sood R; Ranjan S; Poe D; Ramadan UA; Pyykkö I; Kinnunen PK
    Otol Neurotol; 2012 Jun; 33(4):666-73. PubMed ID: 22569149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent.
    Chen SH; Kuo YT; Cheng TL; Chen CY; Chiu YY; Lai JJ; Chang CC; Jaw TS; Wang YM; Liu GC
    Kaohsiung J Med Sci; 2013 May; 29(5):246-53. PubMed ID: 23639510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging assessment of the kinetics of P846, a new gadolinium-based MR contrast medium, in ischemically injured myocardium.
    Jacquier A; Wendland M; Do L; Robert P; Corot C; Higgins CB; Saeed M
    Contrast Media Mol Imaging; 2008; 3(3):112-9. PubMed ID: 18548477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.